Skip to main content

PharmiWeb.Jobs Welcomes Boehringer Ingelheim

Written by: Nola Cadman
Published on: 20 Jun 2022
Category:


Boehringer Ingelheim in their own words...

A successful family owned company
The Boehringer Ingelheim group of companies consists of many cultures and different companies. Here you can find out more about the organisation, business figures, company vision, members of the management board, company history and our commitment to science, culture and the environment.

Boehringer Ingelheim
Improving human and animal health is the goal of the research-based pharmaceutical company Boehringer Ingelheim. The focus is on diseases for which there is not yet a satisfactory treatment option. The company focuses on developing innovative therapies that can extend the lives of patients. In animal health, Boehringer Ingelheim stands for progressive prevention.
 

Related links

Related articles

European Commission Approves Pfizer’s EMBLAVEO® fo

European Commission Approves Pfizer’s EMBLAVEO® for Patients with Multidrug-Resistant Infections and Limited Treatment Options

Rilzabrutinib LUNA 3 phase 3 study met primary end

Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia

Bristol Myers Squibb and Cellares Announce a $380M

Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the Manufacture of CAR T Cell Therapies to Bring the Promise of Cell Therapy to More Patients, Faster